4.6 Article

Simulations of magnetic nanoparticle Brownian motion

Journal

JOURNAL OF APPLIED PHYSICS
Volume 112, Issue 12, Pages -

Publisher

AMER INST PHYSICS
DOI: 10.1063/1.4770322

Keywords

-

Funding

  1. NIH-NCI [1U54CA151662-01]

Ask authors/readers for more resources

Magnetic nanoparticles are useful in many medical applications because they interact with biology on a cellular level thus allowing microenvironmental investigation. An enhanced understanding of the dynamics of magnetic particles may lead to advances in imaging directly in magnetic particle imaging or through enhanced MRI contrast and is essential for nanoparticle sensing as in magnetic spectroscopy of Brownian motion. Moreover, therapeutic techniques like hyperthermia require information about particle dynamics for effective, safe, and reliable use in the clinic. To that end, we have developed and validated a stochastic dynamical model of rotating Brownian nanoparticles from a Langevin equation approach. With no field, the relaxation time toward equilibrium matches Einstein's model of Brownian motion. In a static field, the equilibrium magnetization agrees with the Langevin function. For high frequency or low amplitude driving fields, behavior characteristic of the linearized Debye approximation is reproduced. In a higher field regime where magnetic saturation occurs, the magnetization and its harmonics compare well with the effective field model. On another level, the model has been benchmarked against experimental results, successfully demonstrating that harmonics of the magnetization carry enough information to infer environmental parameters like viscosity and temperature. (C) 2012 American Institute of Physics. [http://dx.doi.org/10.1063/1.4770322]

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Biochemical Research Methods

Mathematical modeling to reveal breakthrough mechanisms in the HIV Antibody Mediated Prevention (AMP) trials

Daniel B. Reeves, Yunda Huang, Elizabeth R. Duke, Bryan T. Mayer, E. Fabian Cardozo-Ojeda, Florencia A. Boshier, David A. Swan, Morgane Rolland, Merlin L. Robb, John R. Mascola, Myron S. Cohen, Lawrence Corey, Peter B. Gilbert, Joshua T. Schiffer

PLOS COMPUTATIONAL BIOLOGY (2020)

Article Medicine, Research & Experimental

Longitudinal study reveals HIV-1-infected CD4+ T cell dynamics during long-term antiretroviral therapy

Annukka A. R. Antar, Katharine M. Jenike, Sunyoung Jang, Danielle N. Rigau, Daniel B. Reeves, Rebecca Hoh, Melissa R. Krone, Jeanne C. Keruly, Richard D. Moore, Joshua T. Schiffer, Bareng A. S. Nonyane, Frederick M. Hecht, Steven G. Deeks, Janet D. Siliciano, Ya-Chi Ho, Robert F. Siliciano

JOURNAL OF CLINICAL INVESTIGATION (2020)

Article Multidisciplinary Sciences

A SARS-CoV-2 vaccine candidate would likely match all currently circulating variants

Bethany Dearlove, Eric Lewitus, Hongjun Bai, Yifan Li, Daniel B. Reeves, M. Gordon Joyce, Paul T. Scott, Mihret F. Amare, Sandhya Vasan, Nelson L. Michael, Kayvon Modjarrad, Morgane Rolland

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)

Article Microbiology

Relationship between CD4 T cell turnover, cellular differentiation and HIV persistence during ART

Charline Bacchus-Souffan, Mark Fitch, Jori Symons, Mohamed Abdel-Mohsen, Daniel B. Reeves, Rebecca Hoh, Mars Stone, Joseph Hiatt, Peggy Kim, Abha Chopra, Haelee Ahn, Vanessa A. York, Daniel L. Cameron, Frederick M. Hecht, Jeffrey N. Martin, Steven A. Yukl, Simon Mallal, Paul U. Cameron, Steven G. Deeks, Joshua T. Schiffer, Sharon R. Lewin, Marc K. Hellerstein, Joseph M. McCune, Peter W. Hunt

Summary: During HIV treatment, individuals suppressed by ART have similar CD4 T cell turnover rates compared to uninfected individuals, but lower absolute proliferation rates and plasma IL-7 levels. Effector memory (TEM) cells have the fastest replacement rates, are highly enriched for integrated HIV-DNA and cell-associated HIV-RNA, and contain the most clonal proviral expansion. Early ART initiation is associated with lower levels of integrated HIV-DNA, cell-associated HIV-RNA, and fractional replacement rates.

PLOS PATHOGENS (2021)

Article Biology

Thresholds for post-rebound SHIV control after CCR5 gene-edited autologous hematopoietic cell transplantation

E. Fabian Cardozo-Ojeda, Elizabeth R. Duke, Christopher W. Peterson, Daniel B. Reeves, Bryan T. Mayer, Hans-Peter Kiem, Joshua T. Schiffer

Summary: Research shows that under certain conditions, HIV viral control can be achieved through autologous transplantation of CCR5 gene-edited hematopoietic stem cells.

ELIFE (2021)

Article Biology

Viral load and contact heterogeneity predict SARS-CoV-2 transmission and super-spreading events

Ashish Goyal, Daniel B. Reeves, E. Fabian Cardozo-Ojeda, Joshua T. Schiffer, Bryan T. Mayer

Summary: SARS-CoV-2 is difficult to contain due to pre-symptomatic transmissions, with a small percentage of infected individuals causing large outbreaks. Infected individuals with SARS-CoV-2 or influenza may be highly contagious for less than a day, typically corresponding to peak viral load. Super-spreader events of SARS-CoV-2 occur when infected individuals shed virus at a very high load and have numerous contacts, potentially due to aerosol transmission.

ELIFE (2021)

Article Multidisciplinary Sciences

Evolution during primary HIV infection does not require adaptive immune selection

David A. Swan, Morgane Rolland, Joshua T. Herbeck, Joshua T. Schiffer, Daniel B. Reeves

Summary: Modern HIV research relies heavily on viral sequencing and population measurements, and the study found that viral evolution during primary infection is mainly driven by the intrinsic fitness distribution rather than positive selection by the host adaptive immune system. The infectivity of mutant variants is primarily determined by an exponential distribution, with most variants being slightly less infectious than their parents.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2022)

Article Virology

Mathematical Modeling of Vaccines That Prevent SARS-CoV-2 Transmission

David A. Swan, Ashish Goyal, Chloe Bracis, Mia Moore, Elizabeth Krantz, Elizabeth Brown, Fabian Cardozo-Ojeda, Daniel B. Reeves, Fei Gao, Peter B. Gilbert, Lawrence Corey, Myron S. Cohen, Holly Janes, Dobromir Dimitrov, Joshua T. Schiffer

Summary: Clinical trials of SARS-CoV-2 vaccines assess efficacy against symptomatic disease, but may not fully differentiate between preventing infection or preventing symptoms. Using mathematical modeling, it is shown that high vaccine efficacy not only requires preventing transmission after infection, but also minimizing symptoms post-infection. Different vaccines may achieve high efficacy through varying mechanisms, with vaccines that offer complete protection against infection or transmission reducing the number of vaccinations needed for herd immunity.

VIRUSES-BASEL (2021)

Article Multidisciplinary Sciences

HIV reservoir quantification using cross-subtype multiplex ddPCR

Noah A. J. Cassidy, Carolyn S. Fish, Claire N. Levy, Pavitra Roychoudhury, Daniel B. Reeves, Sean M. Hughes, Joshua T. Schiffer, Sarah Benki-Nugent, Grace John-Stewart, Dalton Wamalwa, Keith R. Jerome, Julie Overbaugh, Florian Hladik, Dara A. Lehman

Summary: A major barrier to HIV cure research in populations with high HIV burden is the absence of an accurate assay to quantify the replication-competent reservoir across different HIV-1 subtypes. Researchers have modified a subtype B HIV-1 assay to adapt it for use with subtypes A, B, C, D, and CRF01_AE, demonstrating its ability to detect single copies of intact provirus.

ISCIENCE (2022)

Article Biochemical Research Methods

Optimizing clinical dosing of combination broadly neutralizing antibodies for HIV prevention

Bryan T. Mayer, Allan C. deCamp, Yunda Huang, Joshua T. Schiffer, Raphael Gottardo, Peter B. Gilbert, Daniel B. Reeves

Summary: Broadly neutralizing antibodies (bNAbs) are a promising drug for the prevention and treatment of HIV. However, due to differences in breadth, potency, and in vivo longevity, it is important to optimize the composition and dose ratio of combination bNAb therapies to enhance efficacy.

PLOS COMPUTATIONAL BIOLOGY (2022)

Article Chemistry, Analytical

Distinguishing Nanoparticle Aggregation from Viscosity Changes in MPS/MSB Detection of Biomarkers

Dhrubo Jyoti, Scott W. Gordon-Wylie, Daniel B. Reeves, Keith D. Paulsen, John B. Weaver

Summary: Magnetic particle spectroscopy (MPS) is a technique that can detect and quantify molecular biomarkers at very low concentrations. It utilizes the harmonic signals of magnetic nanoparticles induced by a low-frequency magnetic field to provide quantitative information about their microenvironment. One important application involves using antibody-coated nanoparticles to produce biomarker-mediated aggregation, which can be detected using MPS. However, changes in viscosity can also affect the relaxation signals. In this study, a metric is proposed to distinguish between aggregation and viscosity changes.

SENSORS (2022)

Article Multidisciplinary Sciences

Impact of misclassified defective proviruses on HIV reservoir measurements

Daniel B. Reeves, Christian Gaebler, Thiago Y. Oliveira, Michael J. Peluso, Joshua T. Schiffer, Lillian B. Cohn, Steven G. Deeks, Michel C. Nussenzweig

Summary: Most proviruses in people living with HIV are defective, but intact proviruses can lead to viral rebound. The two-probe intact proviral DNA assay (IPDA) found 40-fold more intact proviruses compared to the near full length (nfl) Q4PCR. Both assays showed that defective proviruses did not decay over 10 years. However, the average half-lives of intact proviruses were different: 108 months for IPDA and 65 months for Q4PCR. Misclassified defective proviruses and very long-lived intact proviruses could explain this difference.

NATURE COMMUNICATIONS (2023)

Article Multidisciplinary Sciences

Estimating the contribution of CD4 T cell subset proliferation and differentiation to HIV persistence

Daniel B. Reeves, Charline Bacchus-Souffan, Mark Fitch, Mohamed Abdel-Mohsen, Rebecca Hoh, Haelee Ahn, Mars Stone, Frederick Hecht, Jeffrey Martin, Steven G. Deeks, Marc K. Hellerstein, Joseph M. McCune, Joshua T. Schiffer, Peter W. Hunt

Summary: The persistence of HIV in people on suppressive antiretroviral therapy is linked to physiological mechanisms of CD4+ T cells. This study investigates the longitudinal kinetics of HIV DNA and cell turnover rates in different CD4 cell subsets. The results indicate that HIV clears faster in more proliferative/differentiated CD4 cell subsets and therapies targeting proliferation and differentiation may reduce HIV DNA levels.

NATURE COMMUNICATIONS (2023)

Article Multidisciplinary Sciences

Multi-scale modelling reveals that early super-spreader events are a likely contributor to novel variant predominance

Ashish Goyal, Daniel B. Reeves, Joshua T. Schiffer

Summary: The emergence of new SARS-CoV-2 variants of concern has hindered global efforts to control the COVID-19 pandemic. These variants are characterized by higher transmissibility, worse infection outcomes, and evasion of immunity. They are believed to have originated from animal reservoirs, communities with low surveillance, or individuals with poor immune control. The factors that determine the predominance of these variants are not fully understood. A multi-scale model of SARS-CoV-2 dynamics suggests that stochasticity plays a significant role in determining predominance. Variants with higher infectiousness, early super-spreader events, and the decline of the current dominant variant are more likely to become predominant. Furthermore, most highly infectious variants that infect only a few individuals do not persist in the population. Therefore, reducing super-spreading events can delay or mitigate the emergence of variants of concern.

JOURNAL OF THE ROYAL SOCIETY INTERFACE (2022)

Article Multidisciplinary Sciences

Timing HIV infection with a simple and accurate population viral dynamics model

Daniel B. Reeves, Morgane Rolland, Bethany L. Dearlove, Yifan Li, Merlin L. Robb, Joshua T. Schiffer, Peter Gilbert, E. Fabian Cardozo-Ojeda, Bryan T. Mayer

Summary: This study developed a simple HIV primary infection model using pNLME statistical inference and viral loads from 46 RV217 study participants, achieving a good fit to the data and discovering a strong correlation between Aptima assay values and viral loads.

JOURNAL OF THE ROYAL SOCIETY INTERFACE (2021)

No Data Available